Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd (SHA:600721)

Market Cap	3.50B +38.9%
Revenue (ttm)	388.32M +0.7%
Net Income	40.69M -1.9%
EPS	0.11 -2.4%
Shares Out	384.55M
PE Ratio	85.93
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	19,093,611
Average Volume	27,910,383
Open	9.04
Previous Close	9.10
Day's Range	8.90 - 9.08
52-Week Range	6.40 - 12.60
Beta	0.11
RSI	43.84
Earnings Date	Mar 28, 2026

About SHA:600721

Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd engages in pharmaceutical research and development, clinical trials, biomedicine, commercial properties, and other businesses. It also offers comprehensive contract research organization (CRO) solutions, including one-stop, full-process services for drug R&D, such as Phase I to IV clinical trials, bioequivalence and pharmacokinetics testing, medical science services, R&D project consulting, data management and statistical services, and third-party testing, which covers biological sample analysis, packagi...

• Industry: Restaurants
• Sector: Consumer Discretionary
• Founded: 1959
• Employees: 578
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600721

Financial Performance

In 2025, SHA:600721's revenue was 388.32 million, an increase of 0.66% compared to the previous year's 385.76 million. Earnings were 40.69 million, a decrease of -1.91%.